... benefit from extended endocrine therapy ... "Evaluation of the Sensitivity to EndocrineTherapy (SETER/PR) assay to predict benefit from extended endocrine therapy in the NRG/NSABP B-42 trial.".
Collaborative research led by ARG's Medical Affairs Team and Scientific Advisory Board reinforces the company's commitment to thyroid category leadership ....
There is no current regulatory guidance on determining acceptable concentrations for environmental endocrine disrupting chemicals (EDCs) under the UK Registration, Evaluation, ...
The research team examined the behavioral impacts of exposure to twelve substances suspected or known to be endocrine disruptors during pregnancy (illustrative image) ... bisphenol S, a known endocrine ...
) Outcome of the consultation with Member States, the applicant and EFSA on the pesticide risk assessment for pethoxamid in light of confirmatory information on the endocrine disruption assessment. Published..1 December 2025. Approved. ... Share...Meta data.